Interpharm Biotech Profile
Key Indicators
- Authorised Capital ₹ 1.00 Cr
as on 07-12-2024
- Paid Up Capital ₹ 8.44 M
as on 07-12-2024
- Company Age 25 Year, 2 Months
- Last Filing with ROC 31 Mar 2024
- Satisfied Charges ₹ 4.50 M
as on 07-12-2024
- Revenue 25.91%
(FY 2022)
- Profit -116.97%
(FY 2022)
- Ebitda -112.90%
(FY 2022)
- Net Worth -0.35%
(FY 2022)
- Total Assets -1.66%
(FY 2022)
About Interpharm Biotech
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 1.00 Cr and a paid-up capital of Rs 8.44 M.
The company has closed loans amounting to ₹4.50 M, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Pradeep Agrawal, Samir Chakraborty, Sunita Agrawal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24117GJ1999PTC036759
- Company No.
036759
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
20 Oct 1999
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Interpharm Biotech?
Board Members(5)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Sankalp Agrawal  | Director | 06-Jan-2015 | Current |
| Pradeep Agrawal | Director | 31-Jan-2012 | Current |
| Samir Chakraborty | Director | 06-Jan-2015 | Current |
| Sunita Agrawal | Director | 15-Oct-2018 | Current |
| Sudip Chakraborty | Director | 06-Jan-2015 | Current |
Financial Performance and Corporate Structure Insights of Interpharm Biotech.
Interpharm Biotech Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 25.91% increase. The company also saw a substantial fall in profitability, with a 116.97% decrease in profit. The company's net worth dipped by a decrease of 0.35%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Interpharm Biotech?
Unlock access to Interpharm Biotech's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
Vital Care Pvt LtdActive 32 years 20 daysPradeep Agrawal, Samir Chakraborty and 3 more are mutual person
Shine Pharmaceuticals LimitedActive 30 years 4 monthsPradeep Agrawal and Samir Chakraborty are mutual person
Bhoomi Medicaments LimitedActive 28 years 11 monthsPradeep Agrawal, Samir Chakraborty and 3 more are mutual person
- Vadodara City Police Parivaar Kalyan FoundationActive 2 years 10 months
Pradeep Agrawal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Bank Of Baroda Creation Date: 02 Jul 2003 | ₹4.50 M | Satisfied |
How Many Employees Work at Interpharm Biotech?
Unlock and access historical data on people associated with Interpharm Biotech, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Interpharm Biotech, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Interpharm Biotech's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
